Tag Archives: NIH

Enhanced NIH Funding Vital For Success in Battle Against AIDS

By on .

If there’s any question about the value of U.S. investments in scientific research on HIV/AIDS, Anthony Fauci probably put it to rest today by noting that in the period since HIV first emerged, “we went from a 26-week lifespan to a 40-year-plus life span” for those infected with the virus. Talk about measureable outcomes. That […]

NIH, PEPFAR Look to Strengthen Medical Education In Africa

By on .

The National Institutes of Health (NIH) has teamed up with several other US government agencies to launch a new initiative to strengthen medical education in sub-Saharan Africa. This new program, called the Medical Education Partnership Initiative, is a joint effort by PEPFAR, the CDC, the Department of Defense, and other agencies. It is an effort […]

NIH Funding is "Money Well Spent"

By on .

A new issue brief from The Foundation for AIDS Research and the Treatment Action Group makes a compelling case for increased US investment in NIH research. The issue brief, “A Sound Investment: The Multiplier Effect of AIDS Reserach,” details the broad benefits of AIDS research–not just in advancing HIV treatment but also providing new tools for […]

White House Budget Falls Short on Global HIV & TB

By on .

Although some details are still murky, a first-blush analysis of  Obama Administration’s fiscal year 2011 budget doesn’t look good for US efforts to combat the HIV and tuberculosis epidemics. From treatment to prevention, these global health threats could get short-changed under the White House plan. Let’s start with PEPFAR, the President’s Emergency Plan for AIDS Relief. […]

Budget Deal Reached on Global Health Programs and Needle Exchange Ban

By on .

Lawmakers have finalized the fiscal year 2010 budget for foreign assistance, setting funding for key programs to fight global HIV and TB and reaching a landmark deal to revise the needle-exchange ban. The agreement—expected to pass the House before the end of this week and the Senate before the end of next week—includes some modest […]

NIAID’s Fauci on Tuberculosis: “We have much catching up to do”

By on .

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, delivered a forceful message on the need for a “storm” of attention and resources devoted to developing new TB treatment and prevention efforts. “It is imperative that we transform the way we diagnose, treat, prevent, and control TB — through biomedical research and […]

Consortium of Universities for Global Health Gets Organized, Outlines Priorities

By on .

 This post is by Center Director Christine Lubinski, who attended today’s meeting at the NIH of the Consortium of Universities for Global Health.  How best to nurture and capitalize on a spike in interest in global health studies? Figuring that out is one goal of this week’s two-day meeting of the Consortium of Universities for […]

Fauci: New TB research agenda desperately needed

By on .

This live blog is from the Pacific Health Summit in Seattle, a three-day meeting that opened Tuesday night. Its focus is the global response to multidrug-resistant tuberculosis. Anthony Fauci, the longtime director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, told the Pacific Health Summit today that it […]

Earlier ART=Better Chance for Survival

By on .

In a significant development, the National Institute of Allergy and Infectious Diseases announced that it a trial in Haiti–investigating the impact of earlier ART therapy in HIV-positive patients—would be ended early because the results were overwhelming; the findings showed that HIV-infected adults are more likely to survive if they start antiretroviral drugs before their immune […]

TAG Reports Show Paucity of HIV & TB Research Funding

By on .

Two new reports from the Treatment Action Group highlight the underfunding of scientific research on tuberculosis and related diseases.  The first report is aptly called “Flat-Lined,” and it shows that funding for the National Institutes of Health from 2004 to 2009 has not kept up with inflation, translating into a net dip in research investment […]